NFKB1 and non-small cell lung carcinoma: Previous studies have revealed that NETs could promote NSCLC metastasis through the NF-κB/NLRP3 inflammatory pathway (7) and facilitate metastasis of circulating lung carcinoma cells to the liver after surgery (8).